Kay AB: Asthma and inflammation. J Allergy Clin Immunol. 1991, 87: 893-910.
PubMed
Google Scholar
Gleich GJ, Kita H, Adolphson CR: Eosinophils. In: Samters Immunologic Diseases, edn 5. Edited by Frank MN, Austen KF, Cloman HN, Inanue ER. Boston: Little Brown Co.;. 1995, 205-245.
Google Scholar
Clutterbuck E, Shields JG, Gorden J, Smith SH, Boyd A, Callard RE, Campbell HD, Young IG, Sanderson CJ: Recombinant human interleukin-5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur J Immunol. 1987, 17: 1743-1750.
PubMed
Google Scholar
Clutterbuck EJ, Hirst EMA, Sanderson CJ: Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood. 1989, 73: 1504-1512.
PubMed
Google Scholar
Clutterbuck EJ, Sanderson CJ: Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6 and rh granulocyte-macrophage colony stimulating factor. Blood. 1990, 75: 1774-1779.
PubMed
Google Scholar
Mckenzie ANJ, Ely B, Sanderson CJ: Mutated interleukin-5 monomers are biologically inactive. Mol lmmunol. 1991, 28: 155-158. 10.1016/0161-5890(91)90099-6.
Google Scholar
Hirai K, Yamaguchi M, Misaki Y, Takaishi T, Ohfa K, Morita Y, Ito K, Miyamoto T: Enhancement of human basophil histamine release by interleukin 5. J Exp Med. 1990, 172: 1525-1528.
PubMed
Google Scholar
Resnick MB, Weller PF: Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol. 1993, 8: 349-355.
PubMed
Google Scholar
Tavernier J, Devos R, Cornelis S, Tuypens T, van der Heyden J, Fiers W, Plaetinck G: A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5 specific α chain and a β chain shared with the receptor for GM-CSF. Cell. 1991, 66: 1175-1184.
PubMed
Google Scholar
Miyajima A, Kitamura T, Harada N, Yokota T, Arai KI: Cytokine receptors and signal transduction. Annu Rev lmmunol. 1992, 10: 295-331. 10.1146/annurev.iy.10.040192.001455.
Google Scholar
Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung TT, Payvandi F, Sullivan L, Zurcher JA, Watnick AS: lnterleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis. 1992, 146: 263-265.
PubMed
Google Scholar
Kung TT, Stelts D, Zurcher JA, Watnick AS, Jones H, Mauser PJ, Fernandez X, Umland S, Kreutner W, Chapman RW, Egan RW: Mechanisms of allergic pulmonary eosinophilia in the mouse. J Allergy Clin lmmunol. 1994, 94: 1217-1224.
Google Scholar
Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung TT, Jones H, Watnick AS, Egan RW, Kreutner W, Adams GK: Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis. 1993, 148: 1623-1627.
PubMed
Google Scholar
Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK, Kreutner W, Egan RW, Chapman RW: Effects of an antibody to IL-5 in a monkey model of asthma. Am J Respir Crit Care Med. 1995, 152: 467-472.
PubMed
Google Scholar
Demonchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, Devries K: Bronchoalveolar eosinophilia during antigen-induced late asthmatic reactions. Am Rev Respir Dis. 1985, 131: 373-376.
Google Scholar
Gibson PG, Manning PJ, O'Byrne PM, Girgis-Gabardo A, Dolovich J, Denburg JA, Hargreave FE: Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils and their progenitors. Am Rev Respir Dis. 1991, 143: 331-335.
PubMed
Google Scholar
Hutson PA, Church MK, Clay TP, Miller P, Holgate ST: Early and late-phase bronchoconstriction after antigen challenge of nonanesthetized guinea pigs. 1. The association of disordered airway physiology to leukocyte infiltration. Am Rev Respir Dis. 1988, 137: 548-557.
PubMed
Google Scholar
Ishida K, Thompson RJ, Beattie LL, Wiggs B, Schellenberg RR: Inhibition of antigen-induced airway hyperresponsiveness but not acute hypoxia nor airway eosinophilia, by an antagonist of platelet-activating factor. J Immunol. 1990, 144: 3907-3911.
PubMed
Google Scholar
Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996, 183: 195-201.
PubMed
Google Scholar
Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI: IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996, 4: 15-24.
PubMed
Google Scholar
Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley H, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet. 2000, 356: 2144-2148. 10.1016/S0140-6736(00)03496-6.
PubMed
Google Scholar
Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HAM, Postma DS, Danzig M, Cuss F, Pauwels RA: Results of a phase I trial with SCH5 a humanized anti-IL-5 antibody, in severe persistent asthma [abstract]. Am J Respir Crit Care Med. 2000, 161: A505-
Google Scholar
van Leeuwen BH, Martinson ME, Webb GC, Young IG: Molecular organization of the cytokine gene cluster, involving, the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood. 1989, 73: 1142-1148.
PubMed
Google Scholar
Azuma C, Tanabe T, Konishi M, Kinashi T, Noma T, Matsuda F, Yaoita Y, Takatsu K, Hammarstrom L, Edvard-Smith Cl, Severinson E, Honio T: Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucl Acids Res. 1986, 14: 9149-9158.
PubMed
PubMed Central
Google Scholar
Kinashi T, Harada N, Severinson E, Tanabe T, Sideras P, Konishi M, Azuma C, Tomiaga A, Bergstedt-Lindqvist S, Takahashi M, Matsuda F, Yaoita Y, Takatsu K, Honjo T: Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature. 1986, 324: 70-73.
PubMed
Google Scholar
Miyatake S, Shlomai J, Ken-Ichi A, Ari N: Characterization of the mouse granulocyte macrophage colony-stimulating factor (GM-CSF) gene promoter: nuclear factors that interact with an element shared by three lymphokine genes - those for GM-CSF, interleukin-4 (IL-4), and IL-5. Mol Cell Biol. 1991, 12: 5894-5901.
Google Scholar
Minamitake Y, Kodama S, Katayama T, Adachi H, Tanaka H, Tsujimoto M: Structure of recombinant human interleukin 5 produced by chinese hamster ovary cell. J Biochem. 1990, 107: 292-297.
PubMed
Google Scholar
Takahashi T, Yamaguchi N, Mita S, Yamaguchi Y, Suda T, Tominaga A, Kikuchi Y, Miura Y, Takatsu K: Structural comparison of murine T-cell (Bl 51 Kl 2) derived T-cell-replacing factor (IL-5) with rIL-5: dimer formation is essential for the expression of biological activity. Mol lmmunol. 1990, 27: 911-920. 10.1016/0161-5890(90)90158-V.
Google Scholar
Dickason RR, Huston MM, Huston DP: Delineation of IL-5 domains predicted to engage the IL-5 receptor complex. J Immunol. 1996, 156: 1030-1037.
PubMed
Google Scholar
Zhang J, Kuvelkar R, Murgolo NJ, Taremi SS, Chou CC, Wang P, Billah MM, Egan RW: Mapping and characterization of the epitope(s) of Sch 5 a humanized mAb, that inhibits human IL-5. Int Immunol. 1999, 11: 1935-1944. 10.1093/intimm/11.12.1935.
PubMed
Google Scholar
Kodama S, Tsuruoka N, Tsujimoto M: Role of the C-terminus in the biological activity of human interleukin 5. Biochem Biophys Res Commun. 1991, 178: 514-519.
PubMed
Google Scholar
Tominaga A, Takahashi T, Kikuchi Y, Mita S, Naomi S, Harada N, Yamaguchi N, Takatsu K: Role of carbohydrate moiety of IL-5. J Immunol. 1990, 144: 1345-1352.
PubMed
Google Scholar
Milburn MV, Hassell AM, Lambert MH, Jordan SR, Proudfoot AEI, Graber P, Wells TNC: A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5. Nature. 1993, 363: 172-176. 10.1038/363172a0.
PubMed
Google Scholar
Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev lmmunol. 1989, 7: 145-173. 10.1146/annurev.iy.07.040189.001045.
Google Scholar
Altman A, Coggeshall KM, Mustelin T: Molecular events mediating T cell activation. Adv Immunol. 1990, 48: 227-360.
PubMed
Google Scholar
Naora H, Altin JG, Young IG: TCR-dependent and independent signaling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone DlO.G4.1. J lmmunol. 1994, 152: 5691-5702.
Google Scholar
van Straaten JFM, Dokter WHA, Stulp BK, Vellenga BK: The regulation of interleukin-5 and interleukin-3 gene expression in human T cells. Cytokine. 1994, 6: 229-234.
PubMed
Google Scholar
Garlisi CG, Falcone A, Kung TT, Stelts D, Pennline KG, Beavis AJ, Smith SR, Egan RW, Umland SP: T cells are necessary for TH2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin lmmunol lmmunopathol. 1995, 75: 75-83. 10.1006/clin.1995.1055.
Google Scholar
Umland SP, Razac S, Shah H, Nehrebne DK, Egan RW, Billah MM: Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-γ. Am J Respir Cell Mol Biol. 1998, 18: 631-642.
PubMed
Google Scholar
Umland SP, Shah H, Jakway JP, Shortall J, Razac S, Garlisi CF, Falcone A, Kung TT, Stelts D, Hegde V, Patel M, Billah MM, Egan RW: Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation. Am J Respir Cell Mol Biol. 1999, 20: 481-492.
PubMed
Google Scholar
Bradding P, Roberts JA, Britten KM, Montefort S, Dujukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994, 10: 471-480.
PubMed
Google Scholar
Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron A, Capron M: Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med. 1994, 179: 703-708.
PubMed
Google Scholar
Bazan JF: Structural design and molecular evaluation of a cytokine receptor superfamily. Proc Natl Acad Sci USA. 1990, 87: 6934-6938.
PubMed
PubMed Central
Google Scholar
Migita M, Yamaguchi N, Mita S, Higuchi S, Hitoshi Y, Yosha Y, Tomonaga M, Matsuda I, Tominaga A, Takatsu K: Characterization of the human IL-5 receptors on eosinophils. Cell lmmunol. 1991, 133: 484-497.
Google Scholar
Plaetinck G, van der Heyden J, Tavernier J, Fache I, Tuypens T, Fischkoff S, Fiers W, Devos R: Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells. J Exp Med. 1990, 172: 683-691.
PubMed
Google Scholar
Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A, Takatsu K: Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med. 1992, 175: 341-351.
PubMed
Google Scholar
Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O: Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci. 1994, 19: 222-227. 10.1016/0968-0004(94)90026-4.
PubMed
Google Scholar
Darnell JE, Kerr AM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994, 262: 1415-1420.
Google Scholar
Mul Al-F, Wakao H, O'Farrell A-M, Harada N, Miyajima A: lnterleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologues. EMBO J. 1995, 14: 1166-1175.
Google Scholar
Lopez AF, Shannon MF, Chia M-M, Park L, Vadas MA: Regulation of human eosinophil production and function by interleukin-5. lmmunol Ser. 1992, 57: 549-571.
Google Scholar
Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harad N, Taminaga A, Takatsu K: Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med. 1988, 167: 43-56.
PubMed
Google Scholar
Warringa RAJ, Schweizer RC, Maikoe T, Kujiper PHM, Bruijnzeel PLB, Koenderman L: Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol. 1992, 7: 631-636.
PubMed
Google Scholar
Carlson M, Peterson C, Venge P: The infuence of IL-3, IL-5 and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy. 1993, 48: 437-442.
PubMed
Google Scholar
Kita H, Weiler D, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ: Release of granule proteins from eosinophils cultured with IL-5. J lmmunol. 1992, 149: 629-635.
Google Scholar
Yamaguchi Y, Suda T, Oha S, Toinaga K, Miura Y, Kasahara T: Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 1991, 78: 2542-2547.
PubMed
Google Scholar
Woolley MJ, Denburg JA, Ellis R, Dahlback M, O'Byrne P: Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol. 1994, 11: 600-606.
PubMed
Google Scholar
Ohnishi T, Sur S, Collins DS, Fish J, Gleich GJ, Peters SP: Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J Allergy Clin Immunol. 1993, 92: 607-615.
PubMed
Google Scholar
Wallen N, Kita H, Weiler D, Gleich GJ: Glucocorticoids inhibit cytokine-mediated eosinophil survival. J lmmunol. 1991, 147: 3490-3495.
Google Scholar
Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ: IgA-induced eosinophil degranulation. J Immunol. 1989, 142: 2393-2400.
PubMed
Google Scholar
Minnicozzi M, Anthes JC, Siegel Ml, Billah MM, Egan RW: Activation of phospholipase D in normodense human eosinophils. Biochem Biophys Res Commun. 1990, 170: 540-547.
PubMed
Google Scholar
Petreccia DC, Nauseef WM, Clark RA: Respiratory burst of normal human eosinophils. J Leuk Biol. 1987, 41: 283-288.
Google Scholar
Yazdanbakhsh M, Eckmann CM, Koenderman L, Verhoeven AJ, Roos D: Eosinophils do respond to FMLP. Blood. 1987, 70: 379-383.
PubMed
Google Scholar
Bruynzeel PLB, Kok PTM, Hamelink ML, Kijne AM, Verhagen J: Exclusive leukotrine C4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett. 1985, 189: 350-354. 10.1016/0014-5793(85)81054-1.
PubMed
Google Scholar
Cockcroft S: G-protein-regulated phospholipase C, D, and A2-mediated signalling in neutrophils. Biochim Biophys Acta. 1992, 1113: 135-160.
PubMed
Google Scholar
Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT: Neutrophils and host defense. Ann Intern Med. 1988, 109: 127-142.
PubMed
Google Scholar
Gleich GJ, Adolphson CR: The eosinophilic leukocyte: structure and function. Adv lmmunol. 1986, 39: 177-253.
Google Scholar
Hamann KJ, Barker RI, Ten RM, Gleich GJ: The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl lmmunol. 1991, 94: 202-209.
Google Scholar
Minnicozzi M, Duran WN, Gleich GJ, Egan RW: Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol. 1994, 153: 2664-2670.
PubMed
Google Scholar
Frigas E, Loegering DA, Gleich GJ: Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. J Lab Invest. 1980, 42: 35-43.
Google Scholar
Coeffier E, Joseph D, Vargaftig BB: Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea pigs. Br J Pharmacol. 1994, 113: 749-756.
PubMed
PubMed Central
Google Scholar
Lilly CM, Chapman RW, Sehring SJ, Mauser PJ, Showell HJ, Egan RW, Drazen JM: Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am J Physiol. 1996, 270: L368-L375.
PubMed
Google Scholar
Hakonarson H, Maskeri N, Carter C, Chuang S, Grunstein MM: Autocrine interaction between IL-5 and IL-1β mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J Clin Invest. 1999, 104: 657-667.
PubMed
PubMed Central
Google Scholar
Elbon CL, Jacoby DB, Fryer AD: Pretreatment with an antibody to interleukin 5 prevents loss of pulmonary M2 muscarinic receptor function in antigen challenged guinea pigs. Am J Respir Cell Mol Biol. 1995, 12: 320-328.
PubMed
Google Scholar
Kung TT, Jones H, Adams GK, Umland SP, Kreutner W, Egan RW, Chapman RW, Watnick AS: Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol. 1994, 105: 83-90.
PubMed
Google Scholar
Kung TT, Stelts DM, Zurcher JA, Adams GK, Egan RW, Kreutner W, Watnick AS, Jones H, Chapman RW: Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol. 1995, 13: 360-365.
PubMed
Google Scholar
Kung TT, Stelts D, Zurcher JA, Jones H, Umland SP, Kreutner W, Egan RW, Chapman RW: Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Biol. 1995, 12: 404-409.
Google Scholar
Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cavelier CA, Pauwels RA, Bluethmann H: Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy. 1994, 24: 73-80.
PubMed
Google Scholar
Webb DC, McKenzie ANJ, Koskinen AML, Yang M, Mattes J, Foster PS: Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol. 2000, 165: 108-113.
PubMed
Google Scholar
Mould AW, Ramsay AJ, Matthaei KI, Young IG, Rothenberg ME, Foster PS: The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. J Immunol. 2000, 164: 2142-2150.
PubMed
Google Scholar
Gundel RH, Wegner CD, Letts LG: Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis. 1992, 146: 369-373.
PubMed
Google Scholar
Adelroth E, Rosenhall L, Johansson S, Linden M, Venge P: Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Respir Dis. 1990, 142: 91-99.
PubMed
Google Scholar
Broide DH, Pain MM, Firestein GS: Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest. 1992, 90: 1414-1424.
PubMed
PubMed Central
Google Scholar
Fukuda T, Nakajima H, Fukushima Y, Akutsu I, Namao T, Majima K, Motojima S, Sato Y, Takatsu K, Makino S: Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohistochemistry. J Allergy Clin lmmunol. 1994, 94: 584-593.
Google Scholar
Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB: Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects. Int Arch Allergy Appl lmmunol. 1991, 94: 169-170.
Google Scholar
Krishnaswamy G, Liu MC, Su S-N, Kumai M, Ziao H-Q, Marsh DG, Huang SK: Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am J Respir Cell Mol Biol. 1993, 9: 279-286.
PubMed
Google Scholar
Robinson DS, Ying S, Bentley AM, Meng Q, North J, Durham SR, Kay AB, Hamid Q: Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in asthma. J Allergy Clin Immunol. 1993, 92: 397-403.
PubMed
Google Scholar
Robinson DS, Hamid Q, Ting S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992, 326: 298-304.
PubMed
Google Scholar
Bentley AM, Qiu Meng DS, Robinson DS, Hamid Q, Kay AB, Durham SR: Increases in activated T lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol. 1993, 8: 35-42.
PubMed
Google Scholar
Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel T-F, Villiger B: Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med. 1994, 150: 1030-1048.
Google Scholar
Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB: Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon γ cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol. 1995, 12: 477-487.
PubMed
Google Scholar
Hamid Q, Boguniewicz M, Leung DYM: Differential in situ cytokine gene expession in acute versus chronic atopic dermatitis. J Clin Invest. 1994, 94: 870-876.
PubMed
PubMed Central
Google Scholar
Kay AB, Ying S, Varney J, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q: Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med. 1991, 173: 775-778.
PubMed
Google Scholar
Tanaka Y, Delaporte E, Dubucquoi S, Gounni AS, Porchet E, Capron A, Capron M: lnterleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol. 1994, 103: 589-592.
PubMed
Google Scholar
Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH: Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol. 1993, 151: 3853-3865.
PubMed
Google Scholar
Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, Lowhagen O, Moqbel R, Kay AB, Hamid QA: T cells are the principal source of interleukin 5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol. 1993, 9: 356-360.
PubMed
Google Scholar
Durham SR, Kay AB: Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin Allergy. 1985, 13: 411-418.
Google Scholar
Wardlaw AJ, Dunnett S, Gleich GJ, Collins JV, Kay AB: Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis. 1988, 137: 62-69.
PubMed
Google Scholar
Ohnishi T, Kita H, Weiler D, Sur S, Sedgwick JB, Calhoun WJ, Busse WW, Abrams JS, Gleich GJ: IL-5 is the predominant eosinophil-active cytokine in the antigen induced pulmonary late-phase reaction. Am Rev Respir Dis. 1993, 147: 901-907.
PubMed
Google Scholar
Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR: Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Imunol. 1993, 92: 313-324.
Google Scholar
Sedgwick JB, Calhoun WC, Gleich GJ, Kita H, Abrams JS, Schwartz LB, Volovitz B, Ben-Yaakov M, Busse WW: Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis. 1991, 144: 1274-1281.
PubMed
Google Scholar
Terada N, Konno A, Natori T, Tada H, Togawa K: lnterleukin-5 preferentially recruits eosinophils from vessels in nasal mucosa. Acta Otolaryngol Suppl. 1993, 506: 57-60.
PubMed
Google Scholar
Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K: The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol. 1992, 90: 160-168.
PubMed
Google Scholar
Corrigan CJ, Haczku A, Gemou-Engesaeth V, Dol S, Kukuchi Y, Takatsu K, Durham SR, Kay AB: CD4 T-Lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Am Rev Respir Dis. 1993, 147: 540-547.
PubMed
Google Scholar
Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K: Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy. 1993, 48: 98-106.
PubMed
Google Scholar
Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow J-C: Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis. 1992, 146: 109-115.
PubMed
Google Scholar
Zangrilli JG, Shaver JR, Cirelli RA, Cho SK, Garlisi CG, Falcone A, Cuss FM, Fish JE, Peters SP: sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med. 1995, 151: 1346-1353.
PubMed
Google Scholar
Rolfe FG, Hughes JM, Armour CL, Sewell WA: Inhibition of interleukin-5 gene expression by dexamethasone. lmmunol. 1992, 77: 494-499.
Google Scholar
Egan RW, Athwal E, Bodmer MW, Carter JM, Chapman RW, Chou C-C, Cox MA, Emtage JS, Fernandez X, Genatt N, Indelicato SR, Jenh C-H, Kreutner W, Kung TT, Mauser PJ, Minnicozzi M, Murgolo NJ, Narula SK, Petro ME, Schilling A, Sehring S, Stelts D, Stephens S, Taremi SS, Weiner SH, Zavodny PJ, Zurcher J: Effect of SCH 5 a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity. Arzneimittel-Forschung. 1999, 49: 779-790.
PubMed
Google Scholar
Hart TK, Cook RM, Herzyk DJ, Zia-Amirhosseini P, Williams DM, Bugelski PJ: Inhibition of eosinophilia in monkeys with SB-24 a humanized anti-human IL-5 monoclonal antibody [abstract]. Am J Respir Crit Care Med. 1998, 157: A744-
Google Scholar
Zia-Amirhosseini P, Minthorn E, Benincosa LJ, Hart TK, Hottenstein CS, Tobia LAP, Davis CB: Pharmacokinetics and pharmacodynamics of SB-24 a humanized monoclonal antibody directed to human interleukin-5, in monkeys. J Pharmacol Exp Ther. 1999, 291: 1060-1067.
PubMed
Google Scholar